Document is current
Any future updates will be listed below
-
Authors
Lynn, Anna Y.
Glazer, Peter M.
Saltzman, W. Mark
Stitelman, David H.
-
Funding
Funding for this research was provided by:
Eunice Kennedy Shriver National Institute of Child Health and Human Development (F30 HD106692)
NIH NIGMS (T32GM13665)
NIH SCGE Collaborative Opportunity Fund (UG3/UH3 HL147352, UG3/UH3 HL147352)
National Institute of Biomedical Imaging and Bioengineering (R01 EB032791, R01 EB032791)
- License Information
-
More Information
Article History
Accepted: 13 March 2024
First Online: 19 April 2024
Compliance with Ethical Standards
:
: A.Y.L. declares no conflict of interest. P.M.G. has a patent Compositions and Methods for Embryonic Gene Editing In Vitro pending. P.M.G. and D.H.S. have a patent Compositions and Methods for In Utero Delivery pending. W.M.S. reports grants from NIH during the conduct of the study; grants and personal fees from Xanadu Bio, outside the submitted work; and multiple patents on PACE polymer technology issued to Xanadu Bio.
: This article does not contain any studies with human or animal subjects performed by any of the authors.
